Clinical Trial Update: Adipokine Profile in Patients With Cushing's Disease on Pasireotide Treatment [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing adipokine profiles in patients with Cushing's disease treated with pasireotide has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cushing Disease

Drugs mentioned

• Pasireotide (pasireotide)

Snippet

Sponsor: University of Palermo | Conditions: Cushing Disease | Phase 4 | Status: COMPLETED